Stroke was the fourth leading cause of death in the US last year, accounting for 162,600 deaths, according to preliminary data.

U.S. military veterans face racial and ethnic inequities in access to Novo Nordisk's highly in-demand drugs for diabetes and weight loss, according to a review of patient data published on Monday, the ...

Ozempic (semaglutide) may impact kidney health in certain people, especially those with diabetes. Learn more about what the ...

Popular weight-loss drugs are helping some runners lose weight and crush PRs. Experts have some real concerns.

With the American Heart Association (AHA) and American Stroke Association (ASA) updating their guidelines for preventing ...

No matter how much she ate, she never felt satisfied. But after starting a non-FDA approved GLP-1 agonist—an injectable drug ...

Recent studies have found that Ozempic could lead to more muscle mass loss than traditional weight loss methods.

Karan Johar’s recent weight loss has sparked rumors linking him to Ozempic, a diabetes drug now popular for its weight-loss ...

Novo Nordisk scientist Lotte Knudsen, whose research led to Ozempic and Wegovy, started her career developing laundry ...

You can’t go far lately without seeing news and social media coverage of GLP-1 (glucagon-like peptide-1) receptor agonists ...

Novo Nordisk (NVO) teased some new details about a potential Ozempic successor during a call with investors Tuesday.